TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Middlefield Banc ( (MBCN) ) just unveiled an announcement.
On November 17, 2025, Middlefield Banc Corp. announced that its Board of Directors approved a quarterly cash dividend of $0.21 per common share, consistent with the previous quarter’s dividend. This dividend is payable on December 12, 2025, to shareholders of record as of November 28, 2025, reflecting the company’s stable financial strategy and commitment to shareholder returns.
The most recent analyst rating on (MBCN) stock is a Hold with a $36.00 price target. To see the full list of analyst forecasts on Middlefield Banc stock, see the MBCN Stock Forecast page.
Spark’s Take on MBCN Stock
According to Spark, TipRanks’ AI Analyst, MBCN is a Neutral.
Middlefield Banc’s overall stock score is driven primarily by its stable technical analysis indicators, which show positive momentum. However, financial performance is a concern due to declining revenue growth and profitability. Valuation metrics are reasonable, providing some attractiveness to the stock. The absence of significant earnings call data or corporate events means these factors do not influence the score.
To see Spark’s full report on MBCN stock, click here.
More about Middlefield Banc
Middlefield Banc Corp., headquartered in Middlefield, Ohio, is a bank holding company with total assets of $1.98 billion as of September 30, 2025. Its subsidiary, The Middlefield Banking Company, operates 21 full-service banking centers and one loan production office across Northeast, Central, and Western Ohio. The company’s common shares are traded on the NASDAQ Capital Market under the symbol ‘MBCN’.
Average Trading Volume: 15,457
Technical Sentiment Signal: Buy
Current Market Cap: $277.8M
See more insights into MBCN stock on TipRanks’ Stock Analysis page.